| Primary |
| Coronary Artery Disease |
22.2% |
| Hyperlipidaemia |
22.2% |
| Hypertension |
22.2% |
| Aortic Valve Replacement |
11.1% |
| Cerebral Infarction |
11.1% |
| Hypercholesterolaemia |
11.1% |
|
| Bile Duct Stone |
16.7% |
| Gastrointestinal Haemorrhage |
16.7% |
| Palpitations |
16.7% |
| Pyrexia |
16.7% |
| Rhabdomyolysis |
16.7% |
| Tremor |
16.7% |
|
| Secondary |
| Hypertension |
25.1% |
| Tachyarrhythmia |
14.8% |
| Rheumatoid Arthritis |
9.8% |
| Hyperlipidaemia |
7.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
6.6% |
| Immunosuppressant Drug Therapy |
4.9% |
| Iron Deficiency |
4.9% |
| Osteoporosis |
4.9% |
| Restlessness |
4.9% |
| Coronary Artery Disease |
3.8% |
| Accidental Exposure |
2.2% |
| Acute Myocardial Infarction |
1.6% |
| Iron Deficiency Anaemia |
1.6% |
| Renal Impairment |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Aortic Valve Replacement |
1.1% |
| Drug Use For Unknown Indication |
1.1% |
| Sepsis |
1.1% |
| Asthma |
0.5% |
| Coronary Angioplasty |
0.5% |
|
| Transaminases Increased |
35.0% |
| Rhabdomyolysis |
20.0% |
| Somnolence |
10.0% |
| Vomiting |
10.0% |
| Accidental Exposure To Product |
5.0% |
| Cerebral Infarction |
5.0% |
| Fall |
5.0% |
| Stevens-johnson Syndrome |
5.0% |
| Tendon Pain |
5.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.7% |
| Hypertension |
16.6% |
| Drug Use For Unknown Indication |
10.2% |
| Coronary Artery Disease |
5.9% |
| Diabetes Mellitus |
5.3% |
| Type 2 Diabetes Mellitus |
4.9% |
| Prophylaxis |
4.8% |
| Rheumatoid Arthritis |
4.5% |
| Hypercholesterolaemia |
3.3% |
| Hyperlipidaemia |
3.2% |
| Non-small Cell Lung Cancer |
2.5% |
| Atrial Fibrillation |
2.0% |
| Pain |
1.8% |
| Colitis Ulcerative |
1.6% |
| Stent Placement |
1.6% |
| Premedication |
1.5% |
| Acute Myocardial Infarction |
1.4% |
| Cardiac Failure |
1.4% |
| Hyperparathyroidism Secondary |
1.4% |
| Relapsing-remitting Multiple Sclerosis |
1.4% |
|
| Progressive Multifocal Leukoencephalopathy |
11.4% |
| Cerebrovascular Accident |
6.8% |
| General Physical Health Deterioration |
6.8% |
| Drug Interaction |
5.7% |
| Sepsis |
5.7% |
| Urinary Tract Infection |
5.7% |
| Death |
4.5% |
| Myocardial Infarction |
4.5% |
| Pneumonia |
4.5% |
| Pulmonary Embolism |
4.5% |
| Pyrexia |
4.5% |
| Syncope |
4.5% |
| Transaminases Increased |
4.5% |
| Varicella Zoster Virus Serology Positive |
4.5% |
| Vomiting |
4.5% |
| Dehydration |
3.4% |
| Fall |
3.4% |
| Hypertensive Crisis |
3.4% |
| Hypotension |
3.4% |
| Large Intestine Perforation |
3.4% |
|
| Interacting |
| Hypertension |
29.7% |
| Tachyarrhythmia |
16.2% |
| Rheumatoid Arthritis |
10.8% |
| Coronary Artery Disease |
5.4% |
| Hyperlipidaemia |
5.4% |
| Immunosuppressant Drug Therapy |
5.4% |
| Iron Deficiency |
5.4% |
| Osteoporosis |
5.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
5.4% |
| Restlessness |
5.4% |
| Acute Myocardial Infarction |
2.7% |
| Depression |
2.7% |
|
| Transaminases Increased |
66.7% |
| Rhabdomyolysis |
33.3% |
|
